Skip to product information
PT-141 10mg
$65.00
PT-141 (Bremelanotide) 10mg is a synthetic melanocortin receptor agonist currently being evaluated in research settings for its interaction with central melanocortin signaling pathways.
Scientific investigations have explored its potential involvement in:
• Melanocortin receptor (MC3R and MC4R) activity
• Neuroendocrine signaling mechanisms
• Central nervous system receptor modulation
• Dopaminergic pathway interactions
Preclinical and clinical research models examine its influence on receptor-mediated signaling cascades within hypothalamic and limbic system pathways. Findings remain preliminary and highly dependent on study design, dosing structure, and experimental context.